Challenges and opportunities in prostate cancer surgery in South America: Insights into robot-assisted radical prostatectomies-A perspective.

Autor: Bharadwaj HR; Faculty of Biology, Medicine and Health The University of Manchester Manchester UK., Wireko AA; Faculty of Medicine Sumy State University Sumy Ukraine., Adebusoye FT; Faculty of Medicine Sumy State University Sumy Ukraine., Ferreira T; School of Clinical Medicine University of Cambridge Cambridge UK., Pacheco-Barrios N; Faculty of Medicine, Alberto Hurtado Medical School Cayetano Heredia Peruvian University Lima Peru., Abdul-Rahman T; Faculty of Medicine Sumy State University Sumy Ukraine., Mykolayivna NI; Faculty of Biology, Medicine and Health The University of Manchester Manchester UK.
Jazyk: angličtina
Zdroj: Health science reports [Health Sci Rep] 2023 Aug 21; Vol. 6 (8), pp. e1519. Date of Electronic Publication: 2023 Aug 21 (Print Publication: 2023).
DOI: 10.1002/hsr2.1519
Abstrakt: Background and Aims: Prostate cancer imposes a significant health burden, particularly in South America with its high incidence and mortality rates. This article explores the emergence of robot-assisted radical prostatectomy (RARP) as a potential solution in the region.
Methods: This study relies on a comprehensive review of relevant literature. The analysis highlights the advantages of RARP, identifies impediments to its implementation, and proposes strategies to overcome these barriers.
Results: RARP demonstrates notable benefits, including improved functional outcomes, reduced complications, and minimized incisions. However, the integration of RARP in South America is hindered by challenges such as regional disparities, financial limitations, and data gaps. Limited healthcare infrastructure and a scarcity of skilled professionals further compound the issues.
Conclusion: Despite its potential, RARP faces obstacles to widespread adoption in South America. Strategic solutions encompassing technology investment, healthcare infrastructure enhancement, and workforce training are imperative. Overcoming these challenges can establish RARP as a crucial tool in managing prostate cancer in the region, ultimately enhancing patient care and treatment outcomes.
Competing Interests: The authors declare no conflict of interest.
(© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: